National Healthcare price to free cash flow NHC

Market value divided by free cash flow over the last twelve months, since 2012.

Today, Oct 23, 2026: 25.2×
10-year median: 17.5×
Against its 10-year history: 83rd; percentile: 0 is its lowest day, 100 its highest
10-year range: 4.9× to 48.7×
Peer median: 18.4×

National Healthcare's price to free cash flow is 25.2× as of Oct 23, 2026.

That is above its ten-year median of 17.5×, higher than on 83% of days in the last ten years.

Over that time it ranged from 4.9× in Sep 2020 to 48.7× in Mar 2022.

The median for 10 hospital and care facility stocks of a similar size is 18.4×.

Price to free cash flow over time

median 17.5×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	25.2×	13.7×	26.0×
2025	14.7×	13.1×	18.6×
2024	18.4×	16.4×	26.2×
2023	19.5×	15.0×	42.9×
2022	45.7×	27.2×	48.7×
2021	28.9×	5.3×	32.4×
2020	5.5×	4.9×	19.2×
2019	18.7×	16.2×	21.7×
2018	17.0×	11.9×	18.2×
2017	12.2×	12.2×	39.9×
2016	123×	34.8×	126×
2015	36.0×	24.2×	40.7×
2014	37.9×	12.3×	37.9×
2013	14.2×	10.1×	15.9×
2012	9.7×	9.2×	13.1×

Against its peers

Companies in Medical - Care Facilities nearest National Healthcare's size, closest first, today.

Company	Price to free cash flow
NHCNational Healthcare	25.2×
OPCHOption Care Health	15.4×
AVAHAveanna Healthcare	18.4×
PRVAPrivia Health	n/m
LFSTLifeStance Health	28.4×
CONConcentra Group Holdings Parent	18.7×
SHCSotera Health	45.8×
MDPediatrix Medical	10.4×
ADUSAddus HomeCare	14.7×
PGNYProgyny	12.5×
CHEChemed	20.7×
Peer median	18.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on National Healthcare

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.